Published in Life Sci on January 18, 2008
Preserving mitochondrial function prevents the proteasomal degradation of GTP cyclohydrolase I. Free Radic Biol Med (2012) 0.87
Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress. Antioxid Redox Signal (2015) 0.86
Nitroglycerine-induced nitrate tolerance compromises propofol protection of the endothelial cells against TNF-α: the role of PKC-β2 and NADPH oxidase. Oxid Med Cell Longev (2013) 0.83
Accelerated senescence of endothelial progenitor cells in hypertension is related to the reduction of calcitonin gene-related peptide. J Hypertens (2010) 2.68
Correlations of DDAH1 transcript variants with human endothelial asymmetric dimethylarginine metabolizing activity. Am J Hypertens (2013) 1.98
Cardiomyocyte death in doxorubicin-induced cardiotoxicity. Arch Immunol Ther Exp (Warsz) (2009) 1.41
Evidence for involvement of calcitonin gene-related peptide in nitroglycerin response and association with mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism. J Am Coll Cardiol (2008) 1.40
Recent advances in the study on capsaicinoids and capsinoids. Eur J Pharmacol (2010) 1.40
Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells. Vascul Pharmacol (2005) 1.15
The vanilloid receptor TRPV1: role in cardiovascular and gastrointestinal protection. Eur J Pharmacol (2009) 0.99
Influence of ovariectomy and 17beta-estradiol treatment on insulin sensitivity, lipid metabolism and post-ischemic cardiac function. Int J Cardiol (2004) 0.99
The ALDH2 Glu504Lys polymorphism is associated with coronary artery disease in Han Chinese: Relation with endothelial ADMA levels. Atherosclerosis (2010) 0.99
MicroRNA-130a mediates proliferation of vascular smooth muscle cells in hypertension. Am J Hypertens (2011) 0.98
Role of asymmetric dimethylarginine in inflammatory reactions by angiotensin II. J Vasc Res (2007) 0.97
Effect of hydrogen sulphide on beta-amyloid-induced damage in PC12 cells. Clin Exp Pharmacol Physiol (2007) 0.96
Genistein stimulates the osteoblastic differentiation via NO/cGMP in bone marrow culture. J Cell Biochem (2005) 0.96
Asymmetric dimethylarginine reduced erythrocyte deformability in streptozotocin-induced diabetic rats. Microvasc Res (2006) 0.96
Calcitonin gene-related peptide and hypertension. Peptides (2005) 0.94
Pharmacological effects of xanthones as cardiovascular protective agents. Cardiovasc Drug Rev (2004) 0.93
Asymmetric dimethylarginine induces apoptosis via p38 MAPK/caspase-3-dependent signaling pathway in endothelial cells. J Mol Cell Cardiol (2006) 0.90
Effects of ovariectomy and 17beta-estradiol treatment on the renin-angiotensin system, blood pressure, and endothelial ultrastructure. Int J Cardiol (2008) 0.90
Osteoporosis: prevalence in Taiwanese women. Osteoporos Int (2004) 0.90
Role of VPO1, a newly identified heme-containing peroxidase, in ox-LDL induced endothelial cell apoptosis. Free Radic Biol Med (2011) 0.89
Transient receptor potential vanilloid 1-mediated expression and secretion of endothelial cell-derived calcitonin gene-related peptide. Regul Pept (2008) 0.88
Involvement of prolylcarboxypeptidase in the effect of rutaecarpine on the regression of mesenteric artery hypertrophy in renovascular hypertensive rats. Clin Exp Pharmacol Physiol (2008) 0.87
Role of endogenous nitric oxide synthase inhibitor in gastric mucosal injury. Can J Physiol Pharmacol (2008) 0.87
Involvement of asymmetric dimethylarginine and Rho kinase in the vascular remodeling in monocrotaline-induced pulmonary hypertension. Vascul Pharmacol (2010) 0.87
The inhibitory effect of simvastatin on the ADMA-induced inflammatory reaction is mediated by MAPK pathways in endothelial cells. Biochem Cell Biol (2007) 0.86
Rutaecarpine inhibits hypoxia/reoxygenation-induced apoptosis in rat hippocampal neurons. Neuropharmacology (2008) 0.86
Laparoscopic ureteroureterostomy with the intraoperative retrograde ureteroscopy-assisted technique for inverted-Y ureteral duplication with a blind-ending branch. Urol Int (2015) 0.86
Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway. Vascul Pharmacol (2007) 0.85
Calcitonin gene-related peptide-mediated antihypertensive and anti-platelet effects by rutaecarpine in spontaneously hypertensive rats. Peptides (2008) 0.85
Reduction of NO- and EDHF-mediated vasodilatation in hypertension: role of asymmetric dimethylarginine. Clin Exp Hypertens (2007) 0.85
Asymmetric dimethylarginine induces TNF-alpha production via ROS/NF-kappaB dependent pathway in human monocytic cells and the inhibitory effect of reinioside C. Vascul Pharmacol (2008) 0.85
Fenofibrate decreases asymmetric dimethylarginine level in cultured endothelial cells by inhibiting NF-kappaB activity. Naunyn Schmiedebergs Arch Pharmacol (2005) 0.84
New insights into nitroglycerin effects and tolerance: role of calcitonin gene-related peptide. Eur J Pharmacol (2008) 0.84
Protective effects of evodiamine on myocardial ischemia-reperfusion injury in rats. Planta Med (2004) 0.84
An increase in the synthesis and release of calcitonin gene-related peptide in two-kidney, one-clip hypertensive rats. Regul Pept (2003) 0.83
Rosiglitazone attenuates NF-kappaB-dependent ICAM-1 and TNF-alpha production caused by homocysteine via inhibiting ERK1/2/p38MAPK activation. Biochem Biophys Res Commun (2007) 0.83
All-trans retinoic acid inhibits cobalt chloride-induced apoptosis in PC12 cells: role of the dimethylarginine dimethylaminohydrolase/asymmetric dimethylarginine pathway. J Neurosci Res (2009) 0.83
Involvement of dimethylarginine dimethylaminohydrolase-2 in visfatin-enhanced angiogenic function of endothelial cells. Diabetes Metab Res Rev (2009) 0.83
Inhibitory effect of reinioside C on monocyte-endothelial cell adhesion induced by oxidized low-density lipoprotein via inhibiting NADPH oxidase/ROS/NF-kappaB pathway. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.83
Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction. Biochem Biophys Res Commun (2006) 0.83
Asymmetric dimethylarginine induces tissue factor expression in monocytes via NF-kappaB-dependent pathway: Role in acute coronary syndromes. Atherosclerosis (2008) 0.83
Rutaecarpine prevents hypoxia-reoxygenation-induced myocardial cell apoptosis via inhibition of NADPH oxidases. Can J Physiol Pharmacol (2011) 0.83
Neferine increases STI571 chemosensitivity via inhibition of P-gp expression in STI571-resistant K562 cells. Leuk Lymphoma (2011) 0.83
Reduction of asymmetric dimethylarginine involved in the cardioprotective effect of losartan in spontaneously hypertensive rats. Can J Physiol Pharmacol (2007) 0.82
miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma. Oncol Res Treat (2014) 0.82
Inhibitory effect of calcitonin gene-related peptide on hypoxia-induced rat pulmonary artery smooth muscle cells proliferation: role of ERK1/2 and p27. Eur J Pharmacol (2012) 0.82
Involvement of profilin-1 in angiotensin II-induced vascular smooth muscle cell proliferation. Vascul Pharmacol (2011) 0.82
Involvement of capsaicin-sensitive sensory nerves in cardioprotection of rutaecarpine in rats. Regul Pept (2003) 0.82
The protective effects of rutaecarpine on gastric mucosa injury in rats. Planta Med (2005) 0.82
The cardioprotection of rutaecarpine is mediated by endogenous calcitonin related-gene peptide through activation of vanilloid receptors in guinea-pig hearts. Planta Med (2002) 0.82
Role of asymmetric dimethylarginine in homocysteine-induced apoptosis of vascular smooth muscle cells. Biochem Biophys Res Commun (2007) 0.82
Inhibitory effect of selaginellin on high glucose-induced apoptosis in differentiated PC12 cells: role of NADPH oxidase and LOX-1. Eur J Pharmacol (2012) 0.82
Regulation by DDAH/ADMA pathway of lipopolysaccharide-induced tissue factor expression in endothelial cells. Thromb Haemost (2007) 0.82
A novel pathway of NADPH oxidase/vascular peroxidase 1 in mediating oxidative injury following ischemia-reperfusion. Basic Res Cardiol (2012) 0.82
Expression of apoptosis-associated microRNAs in ethanol-induced acute gastric mucosal injury via JNK pathway. Alcohol (2013) 0.82
Involvement of calcitonin gene-related peptide in the depressor effects of losartan and perindopril in rats. Eur J Pharmacol (2003) 0.82
Protective effects of calcitonin gene-related peptide-mediated evodiamine on guinea-pig cardiac anaphylaxis. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.81
Absence of association between atherosclerotic cerebral infarction and TNFSF4/TNFRSF4 single nucleotide polymorphisms rs1234313, rs1234314 and rs17568 in a Chinese population. J Int Med Res (2014) 0.81
Involvement of CGRP in the inhibitory effect of rutaecarpine on vasoconstriction induced by anaphylaxis in guinea pig. Regul Pept (2005) 0.81
Calcitonin gene-related peptide inhibits angiotensin II-induced endothelial progenitor cells senescence through up-regulation of klotho expression. Atherosclerosis (2010) 0.81
The depressor and vasodilator effects of rutaecarpine are mediated by calcitonin gene-related peptide. Planta Med (2003) 0.81
Involvement of DDAH/ADMA pathway in the pathogenesis of rheumatoid arthritis in rats. Int Immunopharmacol (2013) 0.81
Decrease in endogenous CGRP release in nitroglycerin tolerance: role of ALDH-2. Eur J Pharmacol (2007) 0.81
Protective effect of phloroglucinol against myocardial ischaemia-reperfusion injury is related to inhibition of myeloperoxidase activity and inflammatory cell infiltration. Clin Exp Pharmacol Physiol (2011) 0.81
Inhibitory effect of reinioside C on vascular smooth muscle cells proliferation induced by angiotensin II via inhibiting NADPH oxidase-ROS-ENK1/2-NF-kappaB-AP-1 pathway. Pharmazie (2014) 0.81
Stimulation of calcitonin gene-related peptide synthesis and release: mechanisms for a novel antihypertensive drug, rutaecarpine. J Hypertens (2004) 0.81
Comparing the role of glutathione-S-transferase and mitochondrial aldehyde dehydrogenase in nitroglycerin biotransformation and the correlation with calcitonin gene-related peptide. Eur J Pharmacol (2009) 0.80
Calcitonin gene-related peptide-mediated cardioprotection of postconditioning in isolated rat hearts. Regul Pept (2007) 0.80
Reduction of asymmetric dimethylarginine in the protective effects of rutaecarpine on gastric mucosal injury. Can J Physiol Pharmacol (2008) 0.80
Effect of resveratrol derivative BTM-0512 on high glucose-induced dysfunction of endothelial cells: role of SIRT1. Can J Physiol Pharmacol (2011) 0.80
Effect of estrogen replacement treatment on ischemic preconditioning in isolated rat hearts. Can J Physiol Pharmacol (2004) 0.80
Cardiovascular risk in autoimmune disorders: role of asymmetric dimethylarginine. Eur J Pharmacol (2012) 0.80
Detrimental effects of nicotine on the acute gastric mucosal injury induced by ethanol: role of asymmetric dimethylarginine. Can J Physiol Pharmacol (2008) 0.80
Calcitonin gene-related peptide mediates the cardioprotective effects of rutaecarpine against ischaemia-reperfusion injury in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol (2009) 0.80
Angiotensin-converting enzyme inhibitors prevent LDL-induced endothelial dysfunction by reduction of asymmetric dimethylarginine level. Int J Cardiol (2005) 0.80
Involvement of endothelial cell-derived CGRP in heat stress-induced protection of endothelial function. Vascul Pharmacol (2006) 0.79
Expression of small-conductance calcium-activated potassium channels (SK3) in skeletal muscle: regulation by muscle activity. J Physiol (2008) 0.79
Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level. Can J Physiol Pharmacol (2006) 0.79
Probucol mediates vascular remodeling after percutaneous transluminal angioplasty via down-regulation of the ERK1/2 signaling pathway. Eur J Pharmacol (2007) 0.79
17beta-estradiol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level. Int J Cardiol (2004) 0.79